Q32 Bio Inc. (NASDAQ:QTTB) Receives $12.17 Consensus PT from Analysts

Shares of Q32 Bio Inc. (NASDAQ:QTTB – Get Free Report) have earned an average recommendation of “Hold” from the eight analysts that are presently covering the firm, MarketBeat reports. Six research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12-month target price […]

Leave a Reply

Your email address will not be published.

Previous post Head-To-Head Review: Unum Group (NYSE:UNM) & Employers (NYSE:EIG)
Next post Provident Financial Services, Inc (NYSE:PFS) Receives $24.25 Consensus Target Price from Analysts